Results

1–10 of 62 results for intravitreal injection

Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Endophthalmitis After Intravitreal Injections with 0.05% Aqueous Chlorhexidine vs 5% Povidone-Iodine as Ocular Antiseptics
Murtaza K Adam, MD
Annual Meeting Talks
2022
Noninferiority of 1.7% Povidone–Iodine for Endophthalmitis Prophylaxis After Intravitreal Injections Compared With 5% Povidone–Iodine in an Office Setting
Kamal Kishore, MD, MBBS
Annual Meeting Talks
2022
New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Comparing Post Intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-Hour Period: Randomized Placebo-Controlled Trial
On Demand Cases, Courses, and Papers
2022
Effect of Meditation on Perception of Pain, Anxiety, and Patient Satisfaction During Intravitreal Injections
On Demand Cases, Courses, and Papers
2022
Methotrexate Bubble following Intravitreal Injection for PVR
Zach Seim
Retina Image Bank: Images of the Week
2022
Survey of Intravitreal Injection Technique Among Retina Specialists in Mexico
Gabriela Lopezcarasa Hernandez, MD
On Demand Cases, Courses, and Papers
2021
Utility of a Novel Eyelid Irrigating Retractor on the Post-Intravitreal Injection Patient Experience
Srinivas Sai A Kondapalli, MD
On Demand Cases, Courses, and Papers
2021
Quality Assessment of a New Silicone-Free Syringe Developed for Intravitreal Injections
Gustavo Barreto de Melo, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2021